Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
The most effective PR strategies for FemTech and women’s health brands pair stigma-breaking narratives with clinical authority, then earn third-party validation through media, experts, and partners. This means normalizing sensitive topics, proving claims with evidence, and using compliance-first storytelling that addresses patients, providers, and payers differently.
The market is expanding fast, with the global FemTech category valued at USD 39.29 billion in 2024 and projected to reach USD 97.25 billion by 2030, which heightens competition from buyers and regulators alike. FemTech refers to technology, products, and services that address women’s health needs across every stage of life. To win in this environment, brands should prioritize earned media for building trust, segment messagaging by stakeholder, and anchor every claim in transparent, ethical data practices that meet HIPAA and FTC standards.
FemTech teams face the dual task of destigmatizing health topics and proving clinical value. Underinvestment adds pressure, since women’s health research receives only 6% of private healthcare funding, which slows evidence generation and awareness building.
Health literacy gaps compound the problem, with 36% of US adults lacking basic understanding of their healthcare needs, so clear, plain-language messaging is non-negotiable.
Awareness remains a barrier to adoption in global markets. PR programs need education arcs, not just announcements, to move audiences from curiosity to confidence.
Map the journalist landscape first. Identify and follow reporters with a track record in women’s health and digital health, such as editors from The New York Times, Forbes Women, and The Wall Street Journal, and more. Personalize every pitch, reference recent coverage, and explain why your story advances a beat they already own.
Healthcare journalists reward concise, relevant subject lines coupled with clear, evidence-backed story angles and unique or ground-breaking insights. Use data-driven storytelling that quantifies the health burden, economic impact, and clinical outcomes. Risk-averse healthcare buyers look for third-party validation, which is why earned media and reputable expert voices often influence vendor shortlists in this sector.
For major milestones, consider embargoes and exclusives. An embargo is an agreed date when reporters can publish details, which gives the media time to report with accuracy. An exclusive offers a first look or unique angle to one outlet to secure depth and prominence. Both tactics should be used strategically and paired with unique data or clinical news.Sustained thought leadership also directly converts into reach and credibility.
Lead with normalization and authority. Topics like fertility, sexual wellness, and menopause, and back claims with clinical context and expert voices are key to education and awareness. The market tailwinds around menopause are strong, with approximately 65 million US women projected to be in one of the three menopause stages by 2030. This is a cue to pair empathetic messaging with clear care pathways and cost signals.
Center diverse storytellers. Blend clinician perspectives, founder intent, and patient experience to build trust across audiences. Public activations can accelerate destigmatization when done responsibly. Caria’s menopause billboard in Times Square and Hertility’s 350+ billboards across London are examples of taking the conversation into mainstream spaces to spark informed dialogue. Digital community features like Flo’s Secret Chats show how evidence-based content can live where users already ask sensitive questions.
Invest in owned content that compounds. About 85% of FemTech companies generate under $10 million in annual revenue, so efficient content assets are vital. Blogs still punch above their weight, with 77% of internet users reading blogs and companies that blog earning 97% more links, which strengthens search visibility and media readiness. Publish FAQ explainers, clinical summaries, and data privacy primers that journalists and buyers can reference directly.
Treat compliance as a narrative pillar. The FTC has resolved more than 200 cases involving false or misleading health claims since 1998, so all messaging must be truthful, not misleading, and supported by sound evidence. In April 2024, HHS finalized updates to the HIPAA Privacy Rule that strengthen protections for reproductive health information, which should be explained to users in plain language within PR materials and owned content.
Position against misinformation with clarity. Social platforms host a mix of credible advice and unproven remedies, which makes your clinical bar and disclaimers part of your differentiation. Some brands have taken advocacy stances in public spaces, as seen with Stix’s billboards near crisis pregnancy centers during a period of heightened concern about reproductive rights. Publish data use and retention policies in accessible language, avoid vague wellness claims, and cite third-party validations or certifications where available.
Move beyond vanity metrics to a full-stack model. Use Output, Outtake, Outcome, and Impact to connect activity to adoption and trust. Output covers coverage volume, impressions, and share of voice. Outtake tracks sentiment, social engagement, and website traffic from PR hits. Outcome links PR to business goals like provider education and partnership velocity. Impact measures long-run brand equity and policy influence.
Clinical integration is rising, so your metrics should reflect that. In 2024, 23% of FemTech partnerships involved providers, surpassing pharma for the first time. Track provider mentions, CME (Continuing Medical Education)-style education touchpoints, and references to your evidence base in clinical outlets. Tie message testing to barriers like privacy, access, and cost.
Bolt’s playbook is senior-led, compliance-first, and data-driven. We combine tailored journalist outreach with expert thought leadership and transparent, evidence-based messaging designed for patients, providers, employers, and payers. When platform restrictions limit paid reach, we double down on earned media and authoritative owned content to educate and de-risk buying decisions.
We have turned executive expertise into market momentum across sectors. One client’s CEO became a go-to expert with hundreds of national placements, fueling over 300% growth in a year. In another tech partnership, consistent storytelling delivered 482+ million media impressions in the first year and lifted share of voice from near zero to 20%. If you are building in FemTech, this same model of normalization with authority, relentless media relations, and measurable outcomes is the foundation for durable trust. Explore our work at Bolt PR to see how these elements come together in practice.
FemTech refers to technology, products, and services that address women’s health needs across the lifecycle, including fertility, maternal health, sexual wellness, pelvic floor care, breast health, menopause support, and digital therapeutics.
PR educates the market, provides third-party validation, and builds trust when buyers are risk-averse. It also helps overcome ad-platform restrictions and health literacy gaps by placing credible stories in earned channels that stakeholders already trust.
Lead with clinical evidence and transparency. Acknowledge concerns, share supporting data and disclaimers, and explain data privacy practices in clear language. Treat HIPAA, security, and consent as front-and-center talking points, not fine print.
National outlets like The New York Times, Forbes Women, and The Wall Street Journal have reporters covering women’s health innovation, and specialized medical journals like JAMA publish clinical perspectives. Lifestyle publications can also cover FemTech such as PS, Women’s Health, SELF, SHAPE, and more.
The global FemTech market was valued at USD 39.29 billion in 2024 and is projected to reach USD 97.25 billion by 2030.
FemTech and women’s health brands earn trust when they combine stigma-breaking storytelling with clinical authority, then prove it through third-party validation and measurable outcomes. The opportunity is large, from menopause care demand to employer benefits expansion, but buyers remain cautious and regulators scrutinize claims. Anchor your program in earned media, expert voices, and compliance-first narratives. Define metrics that reflect real adoption and education, not just headline counts. If you are ready to operationalize this approach, our senior-led team can help you build the strategy, content, and media relationships that move markets. Let’s architect a PR plan that normalizes with authority and compounds into durable brand equity.
Not sure where to start?
Contact our team to start the conversation around a customized marketing campaign dedicated to your personalized business goals. From PR to content creation and digital marketing, you tell us how far you want to take your brand, and we’ll do the rest.
We can’t wait to hear from you!
.png)
